For those new to EMD, a little bit of 2021 research that should excite and help you understand why EMD-RX5 / EMD-RX7 below results are so "RedHot" And why IMO Jazz Pharmaceuticals will be all over EMD ATM
1st: EMD-RX5/ EMD-RX7 below results compare to (Epidyolex) are outstanding ( Massive Threat ) IMO
2nd: Jazz Pharmaceutical pays (US$ 7bill ++) for GW Pharmaceuticals, primarily to get access and control of Epidiolex
Jazz agreed to pony up $7.2 billion for cannabinoid hotshot GW Pharmaceuticals, whose epilepsy med Epidiolex could be on its way to blockbuster sales. Epidyolex (world’s only registered CBD medicine )
https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-completes-acquisition-gw-pharmaceuticals
https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw
3rd: Karen Smiths "New Role" Executive Director Emyria EMD
In short: Jazz paid heaps for control of the Epidiolex Drug (world’s only registered CBD medicine) EMD may just have something a fair bit better going of the above results !
Ann: Broker Briefing Presentation, page-2
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(3.26%) |
Mkt cap ! $18.20M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $21.39K | 460.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 269585 | 1 |
View Market Depth
| Last trade - 15.33pm 06/09/2024 (20 minute delay) ? |
| EMD (ASX) Chart |